医疗成本高企,Elevance 下调年度利润预期路透7月17日 - Elevance ELV.N周四下调了年度利润预期,因为该公司预计其政府支持计划的医疗费用将持续上涨。
该公司预计年度利润约 为每股30美元,而 此前预计为每股34.15美元至34.85美元。
根据 LSEG 编制的数据,分析师平均预期为每股 34.23 美元。
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
At the request of the copyright holder, you need to log in to view this content
LOGIN / SIGN UPDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.